115 related articles for article (PubMed ID: 37678622)
1. Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
Wang X; Liu X; Zhong QZ; Wu T; Wu YP; Yang Y; Chen B; Jing H; Tang Y; Jin J; Liu YP; Song YW; Fang H; Lu NN; Li N; Zhai YR; Zhang WW; Wang SL; Chen F; Qi SN; Li YX
Radiother Oncol; 2023 Nov; 188():109902. PubMed ID: 37678622
[TBL] [Abstract][Full Text] [Related]
2. Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015).
Wu Y; Liu X; Imber BS; Zhong QZ; Yang Y; Wu T; Chen SY; Chen B; Song YW; Fang H; Jin J; Liu YP; Jing H; Tang Y; Li N; Lu NN; Wang SL; Chen F; Yin L; Zhang XM; Zhu J; Tsang RW; Yahalom J; Hu C; Men K; Deng M; Xia C; Li YX; Qi SN
Radiother Oncol; 2022 Aug; 173():179-187. PubMed ID: 35667572
[TBL] [Abstract][Full Text] [Related]
3. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.
Haque W; Dabaja B; Tann A; Khan M; Szeja S; Butler EB; Teh BS
Radiother Oncol; 2016 Jul; 120(1):150-5. PubMed ID: 27373911
[TBL] [Abstract][Full Text] [Related]
4. Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I-II follicular lymphoma from the SEER database (2000-2015).
Zhong Q; Liu Y; Wu Y; Liu X; Chen S; Chen B; Su F; Li G; Xu Y; Liu L; Chen F; Qi S; Li Y
Leuk Lymphoma; 2024 Mar; 65(3):312-322. PubMed ID: 37987687
[TBL] [Abstract][Full Text] [Related]
5. Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era.
Sert F; Kamer S; Saydam G; Anacak Y
J Cancer Res Ther; 2018; 14(6):1397-1402. PubMed ID: 30488862
[TBL] [Abstract][Full Text] [Related]
6. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
[TBL] [Abstract][Full Text] [Related]
7. Reduced radiotherapy clinical benefit for primary Waldeyer's ring diffuse large B-cell lymphoma in the rituximab era.
Guan Q; Hong Y; Hu G; Zhou Q; Li L; Qian Z; Zhou S; Ren X; Qiu L; Wang X; Zhang H
Hematol Oncol; 2021 Oct; 39(4):490-497. PubMed ID: 33908077
[TBL] [Abstract][Full Text] [Related]
8. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
[TBL] [Abstract][Full Text] [Related]
9. The Role of Consolidative Radiotherapy after a Complete Response to Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results from a Systematic Review with a Meta-Analysis.
Hu C; Deng C; Zou W; Zhang G; Wang J
Acta Haematol; 2015; 134(2):111-8. PubMed ID: 25925586
[TBL] [Abstract][Full Text] [Related]
10. Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab.
McLaughlin C; Ricco A; Singh R; Mukhopadhyay N; Skoro N; Girma S; Deng X; Song S
Adv Radiat Oncol; 2022; 7(4):100930. PubMed ID: 35814857
[TBL] [Abstract][Full Text] [Related]
11. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
[TBL] [Abstract][Full Text] [Related]
12. A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02).
Chung MJ; Cho WK; Oh D; Eom KY; Kim JH; Kim WC; Lee JH
J Radiat Res; 2019 Oct; 60(5):677-684. PubMed ID: 31251343
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era.
Al-Juhaishi T; Al-Kindi SG
Int J Cardiol; 2021 Sep; 339():146-149. PubMed ID: 34324949
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era.
Bobillo S; Joffe E; Lavery JA; Sermer D; Ghione P; Noy A; Caron PC; Hamilton A; Hamlin PA; Horwitz SM; Kumar A; Matasar MJ; Moskowitz A; Owens CN; Palomba ML; Batlevi CL; Straus D; von Keudell G; Zelenetz AD; Yahalom J; Dogan A; Seshan VE; Younes A
Blood; 2021 Jan; 137(1):39-48. PubMed ID: 32730585
[TBL] [Abstract][Full Text] [Related]
16. Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.
Ma S; Zhang Y; Li Z; Yan H; Xia L; Shi W; Hu Y
Front Oncol; 2020; 10():1157. PubMed ID: 32760674
[No Abstract] [Full Text] [Related]
17. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy.
Shi Z; Das S; Okwan-Duodu D; Esiashvili N; Flowers C; Chen Z; Wang X; Jiang K; Nastoupil LJ; Khan MK
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):569-77. PubMed ID: 23540349
[TBL] [Abstract][Full Text] [Related]
18. Consolidative Radiotherapy after Complete Remission following R-CHOP Immunochemotherapy in Stage III-IV Diffuse Large B-Cell Lymphoma Patients: A Systematic Review and Meta-Analysis.
Choi KH; Lee SJ; Mun SH; Song JH; Choi BO
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568756
[TBL] [Abstract][Full Text] [Related]
19. Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Jegadeesh N; Rajpara R; Esiashvili N; Shi Z; Liu Y; Okwan-Duodu D; Flowers CR; Khan MK
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):107-12. PubMed ID: 25863758
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
